Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Bonadonna

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Clinical and Molecular Allergy : CMA|August 9, 2020
SIRM-SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast mediaMaria Teresa Costantino, Laura Romanini, Francesco Gaeta, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2013
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SMIván Alvarez-Twose, Roberta Zanotti, David González-de-Olano, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 27, 2025
Patient-Reported Outcomes and Provider Perceptions of Systemic Mastocytosis: Results From the PRISM StudyMassimo Triggiani, Jessica Hobart, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology|December 16, 2025
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activationKarin Hartmann, Ivan Alvarez-Twose, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2022
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical PracticePeter Valent, Karin Hartmann, Juliana Schwaab, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2020
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinionsPeter Valent, Cem Akin, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 10, 2019
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation SyndromePeter Valent, Cem Akin, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology|October 29, 2022
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosisBenedetta Sordi, Fiorenza Vanderwert, Francesca Crupi, et al.
Future Oncology (London, England)|September 13, 2018
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registrySerena Merante, Virginia V Ferretti, Chiara Elena, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative GroupKarl Sotlar, Tracy I George, Philip Kluin, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Clinical and Molecular Allergy : CMA|August 9, 2020
SIRM-SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast mediaMaria Teresa Costantino, Laura Romanini, Francesco Gaeta, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2013
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SMIván Alvarez-Twose, Roberta Zanotti, David González-de-Olano, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 27, 2025
Patient-Reported Outcomes and Provider Perceptions of Systemic Mastocytosis: Results From the PRISM StudyMassimo Triggiani, Jessica Hobart, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology|December 16, 2025
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activationKarin Hartmann, Ivan Alvarez-Twose, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2022
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical PracticePeter Valent, Karin Hartmann, Juliana Schwaab, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2020
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinionsPeter Valent, Cem Akin, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 10, 2019
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation SyndromePeter Valent, Cem Akin, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology|October 29, 2022
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosisBenedetta Sordi, Fiorenza Vanderwert, Francesca Crupi, et al.
Future Oncology (London, England)|September 13, 2018
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registrySerena Merante, Virginia V Ferretti, Chiara Elena, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative GroupKarl Sotlar, Tracy I George, Philip Kluin, et al.
Pageof 12